I agree that this site is using cookies. You can find further informations here.
X
Cojutti, Piergiorgio
36  results:
Search for persons X
?
1

Correction to: The pharmacokinetics of recombinant FXIII (c..:

Pasca, Samantha ; Cojutti, PierGiorgio ; Pea, Federico..
Journal of Thrombosis and Thrombolysis.  55 (2022)  1 - p. 195-195 , 2022
Link: https://doi.org/10.1007/..
 
?
2

Treatment of Candida infections with fluconazole in adult l..:

Righi, Elda ; Carnelutti, Alessia ; Baccarani, Umberto...
Transplant Infectious Disease.  21 (2019)  4 - p. , 2019
Link: https://doi.org/10.1111/..
 
?
3

Is meropenem MIC increase against KPC-producing Klebsiella ..:

Cojutti, Piergiorgio ; Sartor, Assunta ; Bassetti, Matteo..
Journal of Global Antimicrobial Resistance.  14 (2018)  - p. 238-241 , 2018
Link: https://doi.org/10.1016/..
 
?
4

Limited sampling strategies for determining the area under ..:

Cojutti, Piergiorgio ; Giangreco, Manuela ; Isola, Miriam.
International Journal of Antimicrobial Agents.  50 (2017)  1 - p. 23-28 , 2017
Link: https://doi.org/10.1016/..
 
?
5

Population Pharmacokinetics and Dosing Considerations for t..:

Cojutti, Piergiorgio ; Pai, Manjunath P. ; Pea, Federico
Clinical Pharmacokinetics.  57 (2017)  8 - p. 989-1000 , 2017
Link: https://doi.org/10.1007/..
 
?
6

Might real-time pharmacokinetic/pharmacodynamic optimisatio..:

Pea, Federico ; Della Siega, Paola ; Cojutti, Piergiorgio...
International Journal of Antimicrobial Agents.  49 (2017)  2 - p. 255-258 , 2017
Link: https://doi.org/10.1016/..
 
?
7

Polytherapy and the risk of potentially inappropriate presc..:

Cojutti, Piergiorgio ; Arnoldo, Luca ; Cattani, Giovanni..
Pharmacoepidemiology and Drug Safety.  25 (2016)  9 - p. 1070-1078 , 2016
Link: https://doi.org/10.1002/..
 
?
8

Monitoring Polypharmacy in Healthcare Systems through a Mul..:

Arnoldo, Luca ; Cattani, Giovanni ; Cojutti, Piergiorgio..
Journal of Public Health Research.  5 (2016)  3 - p. jphr.2016.745 , 2016
Link: https://doi.org/10.4081/..
 
?
9

Might isoniazid plasma exposure be a valuable predictor of ..:

Cojutti, Piergiorgio ; Duranti, Silvia ; Isola, Miriam...
Journal of Antimicrobial Chemotherapy.  71 (2016)  5 - p. 1323-1329 , 2016
Link: https://doi.org/10.1093/..
 
?
10

Variability of Voriconazole Trough Levels in Haematological..:

Cojutti, Piergiorgio ; Candoni, Anna ; Forghieri, Fabio...
Basic & Clinical Pharmacology & Toxicology.  118 (2015)  6 - p. 474-479 , 2015
Link: https://doi.org/10.1111/..
 
?
11

A 5-year survey of antimicrobial susceptibility profiles of..:

Cojutti, Piergiorgio ; Scarparo, Claudio ; Sartor, Assunta...
Diagnostic Microbiology and Infectious Disease.  81 (2015)  1 - p. 53-56 , 2015
Link: https://doi.org/10.1016/..
 
?
12

Linezolid underexposure in a patient co-treated with venlaf..:

Cojutti, Piergiorgio ; Crapis, Massimo ; Bassetti, Matteo..
European Journal of Clinical Pharmacology.  71 (2015)  10 - p. 1285-1286 , 2015
Link: https://doi.org/10.1007/..
 
?
13

Pharmacokinetics and Pharmacodynamics of Continuous Infusio..:

Pai, Manjunath P. ; Cojutti, Piergiorgio ; Pea, Federico
Clinical Pharmacokinetics.  54 (2015)  9 - p. 933-941 , 2015
Link: https://doi.org/10.1007/..
 
?
14

A 1 year retrospective audit of quality indicators of clini..:

Pea, Federico ; Cojutti, Piergiorgio ; Dose, Lucia.
British Journal of Clinical Pharmacology.  81 (2015)  2 - p. 341-348 , 2015
Link: https://doi.org/10.1111/..
 
?
15

Treatment of consecutive episodes of multidrug-resistant ba..:

Pea, Federico ; Cojutti, Piergiorgio ; Merelli, Maria..
International Journal of Antimicrobial Agents.  44 (2014)  6 - p. 570-571 , 2014
Link: https://doi.org/10.1016/..
 
1-15